Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Koji Nagafuji, MD PhD, Toshihiro Miyamoto, MD PhD, Tetsuya Eto, MD PhD, Ryosuke Ogawa, MD PhD, Naoyuki Uchida, MD PhD, Ken Takase, MD, Noriaki Kawano, MD PhD, Tomoaki Fujisaki, MD PhD, Tomohiko Kamimura, MD PhD, Atsushi Wake, MD PhD, Hirokazu Okumura, MD PhD, Yasuhiko Miyazaki, MD PhD, Yasushi Takamatsu, MD PhD, Toshiro Kurokawa, MD PhD, Yuju Ohno, MD PhD, Shouhei Yokota, MP.Path, Koichi Akashi, MD PhD

Blood (2018) 132 (Supplement 1): 3970.

https://doi.org/10.1182/blood-2018-99-112848

Published: 2018

Journal Articles

Analysis of Idiopathic Myelofibrosis Initiating Cell in NOD/SCID/IL2rgKO Mice

Noriyuki Saito, MD, Fumihiko Ishikawa, MD, PhD, Kazuya Shimoda, MD, PhD, Shuro Yoshida, MD, PhD, Yoriko Saito, MD, Mitsuhiro Fukata, MD, Chika Iwamoto, Noriaki Kawano, MD, PhD, Leonard Shultz, PhD, Mine Harada, MD, Koichi Akashi, MD, PhD

Blood (2008) 112 (11): 3715.

https://doi.org/10.1182/blood.V112.11.3715.3715

Published: 2008

Journal Articles

Establishment of Novel Disease Models for Human Acute Type ATL and HTLV-I Carrier Using NOD-scid/IL2rg null Mouse.

Chika Iwamoto, Fumihiko Ishikawa, MD, PhD, Noriaki Kawano, MD, PhD, Noriyuki Saito, MD, Shen M. Yang, MD, PhD, Mitsuhiro Fukata, MD, Yoriko Saito, MD, PhD, Leonard D. Shultz, PhD, Masao Matsuoka, MD, PhD, Mine Harada, MD, PhD

Blood (2007) 110 (11): 2797.

https://doi.org/10.1182/blood.V110.11.2797.2797

Published: 2007

Journal Articles

Transplantation of Primary Human CD34+CD38 - Hematopoietic Stem Cells Recapitulates Idiopathic Myelofibrosis in the NOD/scid/IL2rgKO Mice.

Noriyuki Saito, MD, Fumihiko Ishikawa, MD/PhD, Kazuya Shimoda, MD/PhD, Shuro Yoshida, MD/PhD, Yoriko Saito, MD, Mitsuhiro Fukata, MD, Noriaki Kawano, MD/PhD, Leonard D. Shulz, PhD, Koichi Akashi, MD/PhD, Mine Harada, MD

Blood (2007) 110 (11): 260.

https://doi.org/10.1182/blood.V110.11.260.260

Published: 2007

Journal Articles

Xenotransplantation of Primary CD34+CD38- Hematopoietic Stem Cells Results in an In Vivo Model of Idiopathic Myelofibrosis.

Noriyuki Saito, MD, Fumihiko Ishikawa, MD/PhD, Kazuya Shimoda, MD/PhD, Shuro Yoshida, MD/PhD, Yoriko Saito, MD, Noriaki Kawano, MD/PhD, Leonard D. Shulz, PhD, Koichi Akashi, MD/PhD, Mine Harada, MD

Blood (2006) 108 (11): 666.

https://doi.org/10.1182/blood.V108.11.666.666

Published: 2006

NARROW

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Analysis of Idiopathic Myelofibrosis Initiating Cell in NOD/SCID/IL2rgKO Mice

Establishment of Novel Disease Models for Human Acute Type ATL and HTLV-I Carrier Using NOD-scid/IL2rg null Mouse.

Transplantation of Primary Human CD34+CD38 - Hematopoietic Stem Cells Recapitulates Idiopathic Myelofibrosis in the NOD/scid/IL2rgKO Mice.

Xenotransplantation of Primary CD34+CD38- Hematopoietic Stem Cells Results in an In Vivo Model of Idiopathic Myelofibrosis.

Email alerts

ASH Publications

American Society of Hematology

Minimal Residual Disease (MRD) Status after Induction Therapy Is a Strong Prognostic Factor in the Treatment of Adult Ph (-) Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Study (ALL MRD2008 Study)

Analysis of Idiopathic Myelofibrosis Initiating Cell in NOD/SCID/IL2rgKO Mice

Establishment of Novel Disease Models for Human Acute Type ATL and HTLV-I Carrier Using NOD-scid/IL2rg null Mouse.

Transplantation of Primary Human CD34+CD38 - Hematopoietic Stem Cells Recapitulates Idiopathic Myelofibrosis in the NOD/scid/IL2rgKO Mice.

Xenotransplantation of Primary CD34+CD38- Hematopoietic Stem Cells Results in an In Vivo Model of Idiopathic Myelofibrosis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only